NeuroEM Therapeutics Closes Preliminary Rounds in $5 Million Fairness Elevate to Commercialize Drug-free Alzheimer’s Remedy

NeuroEM Therapeutics, an award-winning clinical-stage biotechnology analysis firm pioneering using radio frequencies to reverse Alzheimer’s illness, has closed preliminary rounds totaling $1.33 million of a $5 million fairness elevate with BlueLake.vc.

The Collection A spherical helps continued progress towards commercialization of NeuroEM’s Transcranial Electromagnetic Remedy (TEMT-RF) to stop and deal with cognitive decline attributable to getting old or Alzheimer’s and different neurodegenerative illnesses.

“BlueLake’s help demonstrates the significance of sustaining our momentum within the execution of key medical, regulatory, and industrial milestones on our journey towards a secure, efficient, drug-free therapy for Alzheimer’s dementia and different neurodegenerative illnesses,” says Chuck Papageorgiou, CEO of NeuroEM Therapeutics. “It fuels the tireless efforts of our researchers, clinicians, engineers, and your entire NeuroEM staff to revive the hope and dignity Alzheimer’s illness has already stolen from hundreds of thousands and to someday stop hundreds of thousands extra from going through this devastating analysis.”

The fairness spherical is led by BlueLake Companion Jamie Rutledge, who additionally joins the NeuroEM Board of Administrators. Rutledge focuses on early-stage investments in breakthrough applied sciences at BlueLake and is a seasoned know-how investor and government with deep experience in strategic funding and innovation throughout the medical know-how and shopper electronics sectors.

He brings greater than 25 years of expertise to NeuroEM, together with senior management roles at Dyson and Lenovo. He beforehand led Lenovo’s Strategic Enterprise Capital and Open Innovation initiatives and directed know-how scouting and strategic investments at Dyson.

“NeuroEM’s pioneering, non-invasive method to treating and stopping Alzheimer’s represents precisely the form of patented, deep tech innovation we champion at BlueLake—transformative, defensible, and grounded in scientific rigor. This method to drug-free therapy and prevention of Alzheimer’s holds large promise in tackling a illness that has eluded efficient options for many years,” stated Rutledge. “We’re proud to help the development of this groundbreaking know-how, and I’m personally honored to assist information NeuroEM because it brings modern, non-invasive therapies to the forefront of neurodegenerative care.”

Provides Papageorgiou, “Jamie’s background in radio frequency methods, embedded units, and product improvement aligns carefully with our core know-how, and his strategic perception might be a beneficial asset as NeuroEM strikes towards commercialization and broader market engagement.”

NeuroEM Therapeutics, a member of StartUp Well being’s Alzheimer’s Moonshot Group, is dedicated to growing, clinically testing, and advertising and marketing its multi-patented TEMT-RF applied sciences that focus on and cut back cognitive decline and restore immune stability within the mind and blood whereas boosting power manufacturing in mind cells—crucial parts for optimum cognitive perform. Early research have demonstrated that, as an Alzheimer’s therapy, TEMT-RF is secure, enhances cognitive perform, and should doubtlessly modify the illness itself.

The corporate’s first industrial product, a light-weight cap designed for at-home use, is at the moment underneath improvement and has proven extraordinary promise in preclinical and medical research. Worn for an hour twice each day, the gadget makes use of quick pulses of power in particular ultra-high frequencies to ship a transcranial electromagnetic therapy that improves key bodily elements within the mind on the root of cognitive decline.

BlueLake Ventures invests in utilized deep tech for the way forward for work and well being, know-how outlined by vital obstacles to entry, similar to robust patent safety or specialised area experience. Its staff consists of skilled operators who’ve constructed and scaled startup firms, held government positions in multi-national firms, constructed partnerships between startups and firms, and deployed strategic enterprise capital in technology-driven companies. By leveraging its experience, sources, and networks, BlueLake goals to speed up the expansion of deep tech improvements that empower each companies and customers.